Abstract
Carbohydrates are important molecular targets in the development of vaccines against cancer, viral and bacterial infections, and many other diseases. However, carbohydrates are usually poorly immunogenic and cannot induce a T cell-dependent immune response that is necessary for effective immunity. To overcome this problem, carbohydrate antigens have to be coupled to an immunogenic carrier molecule, such as a protein, to improve their immunogenicity. To this end, many carbohydrate–protein coupling methods have been developed. A recently established method is based on the introduction of an azido group to carbohydrate antigens during their syntheses, and after the carbohydrate antigens are synthesized, the azido group can be selectively reduced to a free amino group, to which a 4-pentenoyl group can be readily and regiospecifically attached. Thereafter, the C=C bond of the pentenoyl group is ozonolyzed to generate a reactive aldehyde functionality, through which the carbohydrate antigens are linked to carrier proteins by reductive amination. Since the azido group is orthogonal to most transformations involved in carbohydrate synthesis, it can be introduced at an early stage of the synthesis. Moreover, since the pentenoyl group, as well as its aldehyde derivative, is attached to the carbohydrate antigens after they are synthesized, this would significantly simplify the synthetic design of complex carbohydrates, including the design of protecting tactics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kuberan, B., and Lindhardt, R. J. (2000) Carbohydrate based vaccines, Curr Org Chem 4, 653–677.
Ragupathi, G. (1996) Carbohydrate antigens as targets for active specific immunotherapy, Cancer Immunol Immunother 43, 152–157.
Danishefsky, S. J., and Allen, J. R. (2000) From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines, Angew Chem, Int Ed 39, 836–863.
Helling, F., Shang, A., Calves, M., Zhang, S., Ren, S., Yu, R. K., Oettgen, H. F., and Livingston, P. O. (1994) GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines, Cancer Res 54, 197–203.
Livingston, P. O. (1995) Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines, Immunol Rev 145, 147–166.
Chen, C. H., and Wu, T. C. (1998) Experimental vaccine strategies for cancer immunotherapy, J Biomed Sci 5, 231–252.
Jennings, H. J., and Sood, R. K. (1994) Synthetic glycoconjugates as human vaccines, in Neoglycoconjugates: Preparation and Applications (Lee, Y. C., and Lee, R. T., Eds.), pp 325–371, Academic Press, San Diego.
Zou, W., and Jennings, H. J. (2009) Preparation of glycoconjugate vaccines, in Carbohydrate-Based Vaccines and Immunotherapies (Guo, Z., and Boons, G.-J., Eds.), pp 263–312, John Wiley & Sons, Hoboken.
Allen, J. R., and Danishefsky, S. J. (1999) New applications of the n-pentenyl glycoside method in the synthesis and immunoconjugation of fucosyl GM(1): A highly tumor-specific antigen associated with small cell lung carcinoma, J Am Chem Soc 121, 10875–10882.
Xue, J., Pan, Y., and Guo, Z. (2002) Neoglycoprotein cancer vaccines: Synthesis of an azido derivative of GM3 and its efficient coupling to proteins through a new linker, Tetrahedron Lett. 43, 1599–1602.
Pan, Y. B., Chefalo, P., Nagy, N., Harding, C., and Guo, Z. W. (2005) Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines, J Med Chem 48, 875–883.
Wang, Q. L., Ekanayaka, S. A., Wu, J., Zhang, J. P., and Guo, Z. W. (2008) Synthetic and Immunological Studies of 5′-N-Phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier Proteins, Bioconjugate Chem 19, 2060–2067.
Wu, J., and Guo, Z. (2006) Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines, Bioconjug Chem 17, 1537–1544.
Slovin, S. F., Keding, S. J., and Ragupathi, G. (2005) Carbohydrate vaccines as immunotherapy for cancer, Immunol Cell Biol 83, 418–428.
Acknowledgments
Our research on cancer vaccines and cancer immunotherapies is supported by the National Cancer Institute at the National Institutes of Health (CA95142).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wang, Q., Guo, Z. (2011). Coupling Carbohydrates to Proteins for Glycoconjugate Vaccine Development Using a Pentenoyl Group as a Convenient Linker. In: Mark, S. (eds) Bioconjugation Protocols. Methods in Molecular Biology, vol 751. Humana Press. https://doi.org/10.1007/978-1-61779-151-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-61779-151-2_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-150-5
Online ISBN: 978-1-61779-151-2
eBook Packages: Springer Protocols